Research

Sugar industry withheld research into effects of sucrose 50 years ago, study claims

Wed Nov 29, 2017

Sugar Industry Long Downplayed Potential Harms

Tue Nov 28, 2017

What The Industry Knew About Sugar’s Health Effects, But Didn’t Tell Us

Tue Nov 28, 2017

Hiding in plain sight

Tue Nov 21, 2017

A tiny implant promises to simplify how glaucoma drugs are administered, making life easier for aging patients.

Implantable Artificial Kidney Moves Closer to Reality

Mon Nov 13, 2017

A Quest: Insulin-Releasing Implant For Type-1 Diabetes

Tue Nov 7, 2017

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

Thu Nov 2, 2017

Lawrence Livermore National Laboratory

A supercomputer in the Lawrence Livermore National Laboratory will be used in Project ATOM, a new public-private project that aims to speed discovery of new drug therapies.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Computer models speed UCSF scientists toward psychiatric drug discoveries

Mon Oct 23, 2017

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia.

Novel diabetes treatment developed in Desai Lab to power SF-area startup

Thu Oct 19, 2017

Encellin

The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Silicon isn’t just for computers. It can make a pretty good kidney, too.

Mon Oct 9, 2017

Categories: Research